MedTrace Logo

Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART)

NCT03563326 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2018-09-17

No results posted yet for this study

Summary

To investigate the safety and efficacy of intraperitoneal infusion of EpCAM CAR-T cell in advanced gastric cancer with peritoneal metastasis by a prospective nonrandomized controlled trial.

Conditions

  • Neoplasm, Stomach
  • Metastases, Neoplasm
  • Neoplasm Seeding

Interventions

BIOLOGICAL

CAR-T cells targeting EpCAM

Biological: CAR-T cells targeting EpCAM

BIOLOGICAL

Chemotherapy

Chemotherapy: determined by medical Oncologist

Sponsors & Collaborators

  • Jian-Kun Hu

    lead OTHER

Principal Investigators

  • Jian-Kun Hu, M.D. Ph.D. · West China Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-30
Primary Completion
2019-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03563326 on ClinicalTrials.gov